Pure Global AI
NCT06216899Not yet recruiting

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Seattle Children's HospitalClinicalTrials.govother
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Whole-food based smoothie
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Seattle Children's Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jan 10, 2027
Enrollment
60 participants
Primary outcome

Tolerance- Ability to remain on prescribed nutritional therapy

Summary

This study will compare the tolerability and efficacy of conventional formula Exclusive
 Enteral Nutrition (EEN) and whole-food blended smoothie EEN by enrolling a total of 60
 participants with newly diagnosed pediatric Crohn's disease (CD).
 
 Participants will be provided either commercial formula or guided on the preparation of the
 home-blended smoothie. These participants will be given a specific recipe, blender, and be
 provided the food components to the smoothie. The study will total 8 weeks and will assess
 tolerance, clinical outcomes, stool microbiome, and quality of life.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06216899
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06216899 through Pure Global AI's free database. This phase not specified trial is sponsored by Seattle Children's Hospital and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.